Abstract
Uterine cancer is the fourth most frequent cancer in women, with an estimated 34,000 cases and 6000 deaths in the United States in 1996.1 It is the most curable of the 10 most common cancers in women and the most frequent and curable of the gynecologic cancers. Ninety-seven percent of all cancers of the uterus arise from the glands of the endometrium and are known as endometrial carcinomas. The remaining 3 percent of uterine cancers are sarcomas, which are not discussed here. Numerous changes in the pathological description of endometrial cancer, identification of prognostic variables, staging, and treatment have occurred . . .